NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hartlon Vascular, Inc.

Hartlon Vascular, Inc.

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://hartlon.com/

Last Round

Grant

Dec 2, 2024

Total Funding Raised

$100,000

Company Overview

Hartlon Vascular, Inc. is a medical device company that develops drug-eluting, bioresorbable vascular scaffolds for the treatment of peripheral artery disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioresorbable vascular scaffoldBRSdissolvable stentdrug-eluting stentvascular interventionmedical devicearterial blockagebiomaterialsinterventional cardiologyvascular surgeryangioplastybiotech startupmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hartlon Vascular, Inc. Comparables

Compare Hartlon Vascular, Inc. with similar companies based on industry and business-model similarity.

Hartlon Vascular, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
R3 Vascular Inc.
87%
REVA Medical
81%
Elixir Medical Corporation
80%

Hartlon Vascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 2, 2024
GrantJul 21, 2022
AcceleratorFeb 9, 2021

Hartlon Vascular, Inc. Investors

Notable investors and investment history

Hartlon Vascular, Inc. investors
InvestorRounds
Delaware Division of Small BusinessGrant
The Innovation SpaceGrant, Accelerator

Hartlon Vascular, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hartlon Vascular, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hartlon Vascular, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWilmington, Delaware
Year FoundedN/A
Last FundingDec 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.